Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

This publication has 55 references indexed in Scilit:

• A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent
  Nucleic Acids Research, 2012
• Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates
  PLoS Pathogens, 2011
• The ferret as a model organism to study influenza A virus infection
  Disease Models & Mechanisms, 2011
• Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
  Nucleic Acids Research, 2011
• Vaccine Adjuvants: Putting Innate Immunity to Work
  Immunity, 2010
• Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
  Cell Stem Cell, 2010
• AS03_A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
  Clinical Infectious Diseases, 2010
• Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
  New England Journal of Medicine, 2009
• Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
  Clinical and Vaccine Immunology, 2009
• Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts
  Journal of Immunotoxicology, 2008